Neuronetics (STIM) Cash from Investing Activities (2017 - 2026)
Neuronetics (STIM) posted quarterly Cash from Investing Activities of -$172000.0 for Q1 2026, up 21.46% year-over-year from -$141609.0 in Q1 2025, and up 20.37% quarter-over-quarter from -$216000.0 in Q4 2025.
Neuronetics (STIM) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Cash from Investing Activities for 10 consecutive years, with -$172000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 21.46% year-over-year to -$172000.0; the TTM figure through Mar 2026 stood at -$754000.0 (up 72.07% YoY), while the FY2025 annual figure was -$801000.0, up 66.8% from the prior year.
- Cash from Investing Activities rose to -$172000.0 in Q1 2026 per STIM's latest filing, from -$216000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $9.3 million in Q3 2022 and bottomed at -$2.4 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged $119000.0 across 5 years, with a median of -$216000.0 in 2025.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 216.95% — and 2025, when it sank 914.29%.
- Neuronetics' Cash from Investing Activities stood at -$503000.0 in 2022, then retreated by 11.93% to -$563000.0 in 2023, then tumbled by 322.02% to -$2.4 million in 2024, then jumped by 90.91% to -$216000.0 in 2025, then grew by 20.37% to -$172000.0 in 2026.
- Business Quant data shows STIM's Cash from Investing Activities at -$172000.0 in Q1 2026, -$216000.0 in Q4 2025, and -$114000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Neuronetics | 223.77 Mn | 204.34 Mn | 21.22 Mn | -417,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -417,000.00 |
| Jun 30, 2026 | -417,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Dec 31, 2025 | -216,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -252,000.00 |
| Mar 31, 2025 | -219,000.00 |
| Mar 31, 2025 | -219,000.00 |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |